Market revenue in 2023 | USD 248.2 million |
Market revenue in 2030 | USD 510.2 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Oem modules |
Fastest growing segment | OEM Modules |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OEM Modules |
Key market players worldwide | Masimo Corp, Smiths Group PLC, Welch Allyn, Koninklijke Philips NV, Medtronic PLC, Nonin Medical, Nihon Kohden Corp, BD, DiaMedica Therapeutics Inc, ZOLL Medical Corporation, GE HealthCare Technologies Inc Common Stock, Hamilton Thorne Ltd, Hamilton Lane Inc Class A, Mindray Medical International, Schiller Healthcare, Avante Animal Health, Ekso Bionics Holdings Inc, BPL Medical Technologies, Burtons Medical Equipment, Criticare Technologies, Edan Instruments |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to capnography devices market will help companies and investors design strategic landscapes.
Oem modules was the largest segment with a revenue share of 42.71% in 2023. Horizon Databook has segmented the Europe capnography devices market based on oem modules covering the revenue growth of each sub-segment from 2018 to 2030.
Sudden outbreak of corona virus in some major western European countries, like Italy, is expected to boost the usage of capnography devices in respiratory monitoring of patients on ventilation. As capnography devices help confirm the correct placement position of endotracheal tubes and also indicate the difference between successful & failed intubation.
Growing prevalence of chronic diseases, such as diabetes and cancer, is leading to an increase in the demand for efficient medication delivery, thereby driving market growth. According to Cancer Research UK, cancer causes the maximum number of deaths worldwide, which has increased the clinical urgency to implement advanced substitutes, such as capnography devices.
Moreover, the new European Medical Device Regulations implemented in 2019 are expected to increase the barriers for the U.S devices companies marketing their products in Europe. As regulatory policies in Europe are relatively lax in comparison with the U.S., many companies prefer obtaining market clearance in Europe initially.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe capnography devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe capnography devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account